The Journal of Heart and Lung Transplantation
Volume 29, Issue 11 , Pages 1207-1209 , November 2010

On solid-phase antibody assays

  • Octavio E. Pajaro, MD, PhD

      Affiliations

    • Corresponding Author InformationReprint requests: Octavio E. Pajaro, MD, PhD, Division of Cardiothoracic Surgery, University of Alabama at Birmingham, LHRB 780, 1530 3rd Ave S, Birmingham, AL 35294. Telephone: 205-996-9290. Fax: 205-996-6638
    • ,
  • James F. George, PhD

References 

  1. Nwakanma LU, Williams JA, Weiss ES, Russell SD, Baumgartner WA, Conte JV. Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era. Ann Thorac Surg. 2007;84:1556–1562
  2. Shah AS, Nwakanma L, Simpkins C, Williams J, Chang DC, Conte JV. Pretransplant panel reactive antibodies in human lung transplantation: an analysis of over 10,000 patients. Ann Thorac Surg. 2008;85:1919–1924
  3. Glanville AR. Antibody-mediated rejection in lung transplantation: myth or reality?. J Heart Lung Transplant. 2010;29:395–400
  4. Golocheikine A, Nath DS, Basha HI, et al. Increased erythrocyte C4D is associated with known alloantibody and autoantibody markers of antibody-mediated rejection in human lung transplant recipients. J Heart Lung Transplant. 2010;29:410–416
  5. Takemoto SK, Zeevi A, Feng S, et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant. 2004;4:1033–1041
  6. Kfoury AG, Hammond ME. Controversies in defining cardiac antibody-mediated rejection: need for updated criteria. J Heart Lung Transplant. 2010;29:389–394
  7. Zeevi A, Lunz JG, Shapiro R, et al. Emerging role of donor-specific anti-human leukocyte antigen antibody determination for clinical management after solid organ transplantation. Hum Immunol. 2009;70:645–650
  8. Kfoury AG, Renlund DG, Snow GL, et al. A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in heart transplantation. J Heart Lung Transplant. 2009;28:51–57
  9. Kobashigawa J, Mehra M, West L, et al. Report from a consensus conference on the sensitized patient awaiting heart transplantation. J Heart Lung Transplant. 2009;28:213–225
  10. Rose ML, Smith JD. Clinical relevance of complement-fixing antibodies in cardiac transplantation. Hum Immunol. 2009;70:605–609
  11. Smith JD, Hamour IM, Banner NR, Rose ML. C4d fixing, luminex binding antibodies—a new tool for prediction of graft failure after heart transplantation. Am J Transplant. 2007;7:2809–2815
  12. Ross H, Tinckam K, Rao V, West LJ. In praise of ventricular assist devices-mechanical bridge to virtual crossmatch for the sensitized patient. J Heart Lung Transplant. 2010;[E-pub doi: 10.1016/j.healun.2010.02.006]
  13. Stehlik J, Islam N, Hurst D, et al. Utility of virtual crossmatch in sensitized patients awaiting heart transplantation. J Heart Lung Transplant. 2009;28:1129–1134
  14. Pajaro OE, Kirklin JK, George JF. Computational analysis of the single antigen beads used in solid phase assays for the detection of anti-HLA antibodies. J Heart Lung Transplant. 2010;29:S10–S11
  15. Claas FH, Doxiadis II. Human leukocyte antigen antibody detection and kidney allocation within Eurotransplant. Hum Immunol. 2009;70:636–639
  16. Poli F, Cardillo M, Scalamogna M. Clinical relevance of human leukocyte antigen antibodies in kidney transplantation from deceased donors: the North Italy Transplant program approach. Hum Immunol. 2009;70:631–635

PII: S1053-2498(10)00441-9

doi: 10.1016/j.healun.2010.06.016

The Journal of Heart and Lung Transplantation
Volume 29, Issue 11 , Pages 1207-1209 , November 2010

Article Tools

* Image Usage & Resolution